Johnson & Johnson Files For EU Vaccine Approval
US pharmaceutical giant Johnson & Johnson has applied for authorisation for its coronavirus vaccine in the EU with a decision possible by the middle of March. Kingston Mills Professor of Experimental Immunology at Trinity College Dublin spoke to us this morning to explain how this can effect the our current rollout. Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.